Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Foteini Delis

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The International Journal of Neuropsychopharmacology|August 6, 2016
The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric TolerabilityAliou B Gueye, Yaroslaw Pryslawsky, Jose M Trigo, et al.
Neuropharmacology|December 27, 2019
Anti-neuroinflammatory, protective effects of the synthetic microneurotrophin BNN-20 in the advanced dopaminergic neurodegeneration of "weaver" miceVasiliki Panagiotakopoulou, Konstantinos Botsakis, Foteini Delis, et al.
Plos One|June 9, 2016
Chronic Methamphetamine Effects on Brain Structure and Function in RatsPanayotis K Thanos, Ronald Kim, Foteini Delis, et al.
Plos One|February 9, 2017
Correction: Chronic Methamphetamine Effects on Brain Structure and Function in RatsPanayotis K Thanos, Ronald Kim, Foteini Delis, et al.
Translational Psychiatry|February 20, 2024
Multi-level profiling of the Fmr1 KO rat unveils altered behavioral traits along with aberrant glutamatergic functionGeorge Ntoulas, Charalampos Brakatselos, Gerasimos Nakas, et al.
Neuropharmacology|May 3, 2017
BNN-20, a synthetic microneurotrophin, strongly protects dopaminergic neurons in the "weaver" mouse, a genetic model of dopamine-denervation, acting through the TrkB neurotrophin receptorKonstantinos Botsakis, Theodora Mourtzi, Vasiliki Panagiotakopoulou, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 6, 2024
Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male ratsCharalampos Brakatselos, Alexia Polissidis, George Ntoulas, et al.
Neuropharmacology|September 14, 2012
Altered cerebellar organization and function in monoamine oxidase A hypomorphic miceLoai Alzghoul, Marco Bortolato, Foteini Delis, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The International Journal of Neuropsychopharmacology|August 6, 2016
The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric TolerabilityAliou B Gueye, Yaroslaw Pryslawsky, Jose M Trigo, et al.
Neuropharmacology|December 27, 2019
Anti-neuroinflammatory, protective effects of the synthetic microneurotrophin BNN-20 in the advanced dopaminergic neurodegeneration of "weaver" miceVasiliki Panagiotakopoulou, Konstantinos Botsakis, Foteini Delis, et al.
Plos One|June 9, 2016
Chronic Methamphetamine Effects on Brain Structure and Function in RatsPanayotis K Thanos, Ronald Kim, Foteini Delis, et al.
Plos One|February 9, 2017
Correction: Chronic Methamphetamine Effects on Brain Structure and Function in RatsPanayotis K Thanos, Ronald Kim, Foteini Delis, et al.
Translational Psychiatry|February 20, 2024
Multi-level profiling of the Fmr1 KO rat unveils altered behavioral traits along with aberrant glutamatergic functionGeorge Ntoulas, Charalampos Brakatselos, Gerasimos Nakas, et al.
Neuropharmacology|May 3, 2017
BNN-20, a synthetic microneurotrophin, strongly protects dopaminergic neurons in the "weaver" mouse, a genetic model of dopamine-denervation, acting through the TrkB neurotrophin receptorKonstantinos Botsakis, Theodora Mourtzi, Vasiliki Panagiotakopoulou, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 6, 2024
Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male ratsCharalampos Brakatselos, Alexia Polissidis, George Ntoulas, et al.
Neuropharmacology|September 14, 2012
Altered cerebellar organization and function in monoamine oxidase A hypomorphic miceLoai Alzghoul, Marco Bortolato, Foteini Delis, et al.
Pageof 4